Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125941874 | 12594187 | 4 | F | 201603 | 20160830 | 20160726 | 20160909 | EXP | US-BAYER-2016-065258 | BAYER | 79.00 | YR | E | F | Y | 116.00000 | KG | 20160909 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125941874 | 12594187 | 1 | PS | ADEMPAS | RIOCIGUAT | 1 | Oral | UNK | 204819 | ||||||||||
| 125941874 | 12594187 | 2 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 0.5 MG, TID | BXH30T1 | 204819 | .5 | MG | TID | ||||||
| 125941874 | 12594187 | 3 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 1 MG, TID | BXH9111 | 204819 | 1 | MG | TID | ||||||
| 125941874 | 12594187 | 4 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 1.5 MG, TID | BXH4HJ1 | 204819 | 1.5 | MG | TID | ||||||
| 125941874 | 12594187 | 5 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 2 MG, TID | BXH7CN1 | 204819 | 2 | MG | TID | ||||||
| 125941874 | 12594187 | 6 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 2.5 MG, TID | BXH8FC1 | 204819 | 2.5 | MG | TID | ||||||
| 125941874 | 12594187 | 7 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 2.5 MG, TID, LAST SHIPPED ON 21-JUL-2016 | BXH8FC2 | 204819 | 2.5 | MG | TID | ||||||
| 125941874 | 12594187 | 8 | SS | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 125941874 | 12594187 | 9 | C | TRACLEER | BOSENTAN | 1 | UNK | 0 | |||||||||||
| 125941874 | 12594187 | 10 | C | SILDENAFIL. | SILDENAFIL | 1 | (HISTORICAL DRUG) | 0 | |||||||||||
| 125941874 | 12594187 | 11 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 125941874 | 12594187 | 12 | C | BUMEX | BUMETANIDE | 1 | 1 MG, QD | 0 | 1 | MG | QD | ||||||||
| 125941874 | 12594187 | 13 | C | WELLBUTRIN XL | BUPROPION HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125941874 | 12594187 | 14 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 125941874 | 12594187 | 15 | C | DEXLANSOPRAZOLE | DEXLANSOPRAZOLE | 1 | 0 | ||||||||||||
| 125941874 | 12594187 | 16 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | 0 | ||||||||||||
| 125941874 | 12594187 | 17 | C | LASIX | FUROSEMIDE | 1 | 0 | ||||||||||||
| 125941874 | 12594187 | 18 | C | NEURONTIN | GABAPENTIN | 1 | 0 | ||||||||||||
| 125941874 | 12594187 | 19 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 0 | ||||||||||||
| 125941874 | 12594187 | 20 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 125941874 | 12594187 | 21 | C | CYTOMEL | LIOTHYRONINE SODIUM | 1 | 0 | ||||||||||||
| 125941874 | 12594187 | 22 | C | MAG-OX | MAGNESIUM OXIDE | 1 | 0 | ||||||||||||
| 125941874 | 12594187 | 23 | C | ANTIVERT | MECLIZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125941874 | 12594187 | 24 | C | ADALAT CC | NIFEDIPINE | 1 | 0 | PROLONGED-RELEASE TABLET | |||||||||||
| 125941874 | 12594187 | 25 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 125941874 | 12594187 | 26 | C | KLOR-CON | POTASSIUM CHLORIDE | 1 | 0 | ||||||||||||
| 125941874 | 12594187 | 27 | C | PRAVACHOL | PRAVASTATIN SODIUM | 1 | 0 | ||||||||||||
| 125941874 | 12594187 | 28 | C | METAMUCIL | PLANTAGO SEED | 1 | 0 | ||||||||||||
| 125941874 | 12594187 | 29 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125941874 | 12594187 | 30 | C | ALDACTONE | SPIRONOLACTONE | 1 | 0 | ||||||||||||
| 125941874 | 12594187 | 31 | C | URSO | URSODIOL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125941874 | 12594187 | 1 | Pulmonary arterial hypertension |
| 125941874 | 12594187 | 2 | Pulmonary arterial hypertension |
| 125941874 | 12594187 | 3 | Pulmonary arterial hypertension |
| 125941874 | 12594187 | 4 | Pulmonary arterial hypertension |
| 125941874 | 12594187 | 5 | Pulmonary arterial hypertension |
| 125941874 | 12594187 | 6 | Pulmonary arterial hypertension |
| 125941874 | 12594187 | 7 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125941874 | 12594187 | HO |
| 125941874 | 12594187 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125941874 | 12594187 | Alopecia | |
| 125941874 | 12594187 | Arthritis infective | |
| 125941874 | 12594187 | Cardiac failure congestive | |
| 125941874 | 12594187 | Dizziness | |
| 125941874 | 12594187 | Dyspepsia | |
| 125941874 | 12594187 | Dyspnoea | |
| 125941874 | 12594187 | Dyspnoea exertional | |
| 125941874 | 12594187 | Fluid overload | |
| 125941874 | 12594187 | Furuncle | |
| 125941874 | 12594187 | Gastrooesophageal reflux disease | |
| 125941874 | 12594187 | Generalised oedema | |
| 125941874 | 12594187 | Gout | |
| 125941874 | 12594187 | Local swelling | |
| 125941874 | 12594187 | Malaise | |
| 125941874 | 12594187 | Nasopharyngitis | |
| 125941874 | 12594187 | Nausea | |
| 125941874 | 12594187 | Oedema | |
| 125941874 | 12594187 | Oedema peripheral | |
| 125941874 | 12594187 | Pneumonia | |
| 125941874 | 12594187 | Postoperative wound infection | |
| 125941874 | 12594187 | Procedural pain | |
| 125941874 | 12594187 | Squamous cell carcinoma of skin | |
| 125941874 | 12594187 | Weight decreased | |
| 125941874 | 12594187 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125941874 | 12594187 | 1 | 20160318 | 0 |